IBM (IBM) holds its Think 2026 event this week in Boston, which will feature presentations on a major recent acquisition and quantum computing. CEO Arvind Krishna will present the opening keynote ...

Confluent Medical Technologies (Confluent), a leading medical device and materials science contract manufacturer specializing in Nitinol and polymer components, announces the opening of their Nitinol ...

Confluent Medical Technologies, Inc. (“Confluent”), a leading medical device and materials science contract manufacturer specializing in Nitinol and polymer components, today announced that Tom Testa, ...

Big Blue says the announcements address the defining challenge facing enterprises: many have invested heavily in AI, but only ...

Confluent's Nitinol Wire Center of Excellence will double the nitinol supplier's wire output and allow another facility to ...

Data connectivity company Confluent announced Monday that it is acquiring startup WarpStream for an undisclosed amount to diversify its data streaming offerings. It’s an important deal that shines ...

Confluent COO Tom Testa will oversee the nitinol supplier's operations, supply chain, product development and environmental ...

Recently trading at $22.41, Confluent stock has rallied 52% from the new post-IPO low of $14.69 reached on November 2. Shares of Confluent (CFLT) have begun to rebound following a one-day plunge of 42 ...

It has been just under four years since Confluent (NASDAQ: CFLT) made its stock market debut in June 2021. A look at its stock price chart will show that investors in the data streaming specialist ...

Oppenheimer analyst Ittai Kidron initiated coverage on Confluent Inc (NASDAQ:CFLT) with an Outperform rating and a price target of $37. The analyst said that Confluent’s ability to bring event ...

Confluent and Snowflake both face near-term macro headwinds. Confluent still doesn’t have a clear path toward profitability. Snowflake’s profitability is improving, even as its revenue growth cools ...

Confluent’s stock has slumped below its IPO price. Its business is still growing, but it faces macro and competitive headwinds. It needs to expand its ecosystem to widen its moat. Confluent was ...